Search Results - Seto, Takashi

Refine Results
  1. 1
    Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

    Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date by Akamine, Takaki, Toyokawa, Gouji, Tagawa, Tetsuzo, Seto, Takashi

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Atezolizumab in non-squamous non-small cell lung cancer

    Atezolizumab in non-squamous non-small cell lung cancer by Akamine, Takaki, Toyokawa, Gouji, Tagawa, Tetsuzo, Seto, Takashi

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in EGFR–Mutated Lung Cancer

    Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in EGFR–Mutated Lung Cancer by Haratake, Naoki, Misumi, Toshihiro, Yamanaka, Takeharu, Seto, Takashi

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Plerixafor stem cell mobilization in Japanese children: A post‐marketing study

    Plerixafor stem cell mobilization in Japanese children: A post‐marketing study by Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene

    Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene by Kometani, Takuro, Sugio, Kenji, Osoegawa, Atsushi, Seto, Takashi, Ichinose, Yukito

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

    Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma by Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma

    Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma by Osoegawa, Atsushi, Kometani, Takuro, Fukuyama, Seiichi, Hirai, Fumihiko, Seto, Takashi, Sugio, Kenji, Ichinose, Yukito

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study

    Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study by Tsukada, Nobuhiro, Nishikori, Momoko, Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi, Iida, Shinsuke

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

    Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan by Seto, Takashi, Nogami, Naoyuki, Yamamoto, Nobuyuki, Atagi, Shinji, Tashiro, Naoki, Yoshimura, Yoko, Yabuki, Yutaka, Saka, Hideo

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation

    Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation by Takamori, Shinkichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Toyozawa, Ryo, Seto, Takashi, Yamaguchi, Masafumi, Okamoto, Tatsuro

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status

    Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status by Matsubara, Taichi, Seto, Takashi, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamaguchi, Masafumi, Okamoto, Tatsuro

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy

    Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy by Matsubara, Taichi, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamaguchi, Masafumi, Seto, Takashi, Okamoto, Tatsuro

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data

    Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual pa... by Taniguchi, Yuri, Okamoto, Hiroaki, Shimokawa, Tsuneo, Sasaki, Tomonari, Seto, Takashi, Niho, Seiji, Ohe, Yuichiro, Saigusa, Yusuke

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab

    The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab by Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Toyozawa, Ryo, Miura, Naoko, Shimokawa, Mototsugu, Yamaguchi, Masafumi, Seto, Takashi, Takenoyama, Mitsuhiro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report

    Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report by Miura, Naoko, Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Toyozawa, Ryo, Yamaguchi, Masafumi, Seto, Takashi, Taguchi, Kenichi, Takenoyama, Mitsuhiro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer

    Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer by Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Matsubara, Taichi, Haratake, Naoki, Miura, Naoko, Toyozawa, Ryo, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient

    Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient by Takamori, Shinkichi, Takenoyama, Mitsuhiro, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Yamaguchi, Masafumi, Toyozawa, Ryo, Seto, Takashi, Okamoto, Tatsuro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC

    Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC by Toyozawa, Ryo, Haratake, Naoki, Toyokawa, Gouji, Matsubara, Taichi, Takamori, Shinkichi, Miura, Naoko, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro, Seto, Takashi

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

    Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC by Toyozawa, Ryo, Haratake, Naoki, Toyokawa, Gouji, Matsubara, Taichi, Takamori, Shinkichi, Miura, Naoko, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro, Seto, Takashi

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study

    Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Explorato... by Hosomi, Yukio, Seto, Takashi, Nishio, Makoto, Goto, Koichi, Yamamoto, Noboru, Okamoto, Isamu, Tajima, Kosei, Kajihara, Yusuke, Yamamoto, Nobuyuki

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: